| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |